Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1cand Hypoglycemia-Reference-Cited by-同舟云学术

Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1cand Hypoglycemia

Published:2017-10-13 Issue:12 Volume:40 Page:1719-1726
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Dassau Eyal^ORCID,Pinsker Jordan E.^ORCID,Kudva Yogish C.,Brown Sue A.,Gondhalekar Ravi,Dalla Man Chiara,Patek Steve,Schiavon Michele,Dadlani Vikash,Dasanayake Isuru^ORCID,Church Mei Mei,Carter Rickey E.,Bevier Wendy C.,Huyett Lauren M.,Hughes Jonathan,Anderson Stacey,Lv Dayu,Schertz Elaine,Emory Emma,McCrady-Spitzer Shelly K.,Jean Tyler,Bradley Paige K.,Hinshaw Ling,Laguna Sanz Alejandro J.,Basu Ananda^ORCID,Kovatchev Boris,Cobelli Claudio^ORCID,Doyle Francis J.^ORCID

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Science

Urdang Family Foundation

Italian Ministero dell’Università e della Ricerca Scientifica

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes

2. Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas